Advanced Search

Share

English Português

Home Most often read

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

See more

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2024

1.6

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2024

2.0

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2024

0.360

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2024

0.754

View more metrics

Open Access Option

Journal Information

Most often read

Vol. 48. Issue. 1

3396

Lymphoma-associated hemophagocytic lymphohistiocytosis

Thomás de Souza Patto Marcondes, Carlos Sérgio Chiattone, Rafael Dezen Gaiolla

Hematol Transfus Cell Ther. 2026;48:106087

3396

Full text access

Share

1102

Evaluation of the effects of fucoidan extracted from sargassum angustifolium on coagulation factors and biochemical parameters in male Wistar rats

Asma Dehghani, Ameneh Khoshvaghti, Narges Obeidi

Hematol Transfus Cell Ther. 2026;48:106073

1102

Full text access

Share

1006

Outcomes after bone marrow versus peripheral blood haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis

Muhammad Kashif Amin, Moazzam Shahzad, Abat Khan, Valiko Begiashvili, Ushna Khan, Matthew McGuirk, Shaun DeJarnette, Sibgha Gull Chaudhary, ... Muhammad Umair Mushtaq

Hematol Transfus Cell Ther. 2026;48:106222

1006

Full text access

Share

989

In patients with suspected thrombotic thrombocytopenic purpura, what is the optimal time to therapeutic plasma exchange?

Alexandre Soares Ferreira Junior, Kate Sanborn, Morgana Pinheiro Maux Lessa, Alexander Gordee, Maragatha Kuchibhatla, Allison O. Taylor, Matthew S. Karafin, Oluwatoyosi A. Onwuemene

Hematol Transfus Cell Ther. 2026;48:106223

989

Full text access

Share

988

Identification of an in-frame insertion in ACKR1 in five individuals from Agri community, India

Shaikh Roshan, Solanki Prakash, Ghosh Kanjaksha, Gorakshakar Ajit

Hematol Transfus Cell Ther. 2026;48:106075

988

Full text access

Share

898

Changes in the microbiota following allogeneic hematopoietic stem cell transplantation: A potential bioguide for clinical outcome?

Ekin Ece Gurer-Kluge, Fatma Savran Oguz, Zerrin Aktas, Sevgi Kalayoglu Besisik, Ugur Sezerman, Oral Oncul, Zafer Gulbas

Hematol Transfus Cell Ther. 2026;48:106074

898

Full text access

Share

821

Obstetrical use of intravenous immunoglobulin: A single-centre retrospective study

Roy Khalife, Bonnie Niu, Iris Perelman, Darine El-Chaâr, Dean Fergusson, Alan Karovitch, Johnathan Mack, Melanie Tokessy, ... Alan Tinmouth

Hematol Transfus Cell Ther. 2026;48:106225

821

Full text access

Share

808

Integrating comprehensive care in the management of sickle cell disease patients in Nigeria

Efobi Chilota Chibuife, Nri-Ezedi Chisom Adaobi, Chilaka Ugochinyere Jenny, Okoye Helen Chioma, Anigbogu Ikechukwu Okwudili, Okwummuo Emeka Paul, Ogundeji Sunday Peter, Eze Onyinye Ezinne

Hematol Transfus Cell Ther. 2026;48:106091

808

Full text access

Share

784

Hereditary thrombocytopenias: the challenge of increasing frequency and differential diagnosis

Rafiye Çiftçiler

Hematol Transfus Cell Ther. 2026;48:106076

784

Full text access

Share

770

Cold-stored platelets: A systematic review of recovery in healthy adults and chest drain output in cardiothoracic surgery patients

Caleb Keane, Heba Sharif, Denise Jackson

Hematol Transfus Cell Ther. 2026;48:106226

770

Full text access

Share

710

Assessment of the neutrophil-to-lymphocyte ratio as a prognostic marker in patients with newly diagnosed diffuse large B-cell lymphoma: A Colombian Cohort Study

Paula María Sánchez, Juan Felipe Combariza-Vallejo

Hematol Transfus Cell Ther. 2026;48:106237

710

Full text access

Share

622

First report of perioperative iptacopan interruption in paroxysmal nocturnal hemoglobinuria without breakthrough hemolysis

Katsuhiro Tokuda, Tatsuki Morioka, Shoya Arai, Takuji Matsuo, Kensuke Matsumoto, Ryosuke Shirasaki, Jun Ooi, Haruko Tashiro

Hematol Transfus Cell Ther. 2026;48:106235

622

Full text access

Share

564

Efficacy and safety analysis of the use of ibrutinib associated with rituximab for the first-line treatment of patients with chronic lymphocytic leukaemia

Aline do Nascimento, Daniel da Silva Pereira Curado, Thais Montezuma, Wallace Breno Barbosa, Juliana Machado-Rugolo, Mariana Millan Fachi

Hematol Transfus Cell Ther. 2026;48:106234

564

Full text access

Share

540

Mechanistic insights into the antiproliferative effect of the redox-active iron chelator Dp44mT on multiple myeloma cell lines

Aarti Sharma, Latha Pathangey, Sinto Sebastian Chirackal, Kiran K. Mangalaparthi, Akhilesh Pandey, Rafael Fonseca, Sundararaman Swaminathan

Hematol Transfus Cell Ther. 2026;48:106233

540

Full text access

Share

525

Platelet transfusion in end-of-life adult care

Diana Cibele, Fernanda Trigo, Miguel Barbosa, Jorge Almeida, José Artur Paiva, Edna Gonçalves, João Brito, José Teixeira, Fernando Araújo

Hematol Transfus Cell Ther. 2026;48:106228

525

Full text access

Share

516

Mesenchymal stromal cells secretory pattern contributes to oncoinflammatory bone marrow microenvironment in polycythemia vera

Juçara Gastaldi Cominal, Maira da Costa Cacemiro, Giovana Michelassi Berbel, Rifkath Marie Laurance Rahimy, Gisele Vieira Rocha, Dalila Lucíola Zanette, Maria Carolina Oliveira, Lorena Lobo de Figueiredo-Pontes, ... Fabíola Attié de Castro

Hematol Transfus Cell Ther. 2026;48:106224

516

Full text access

Share

449

Beyond the crisis: Tracking chronic neuropathic pain in sickle cell disease using Douleur Neuropathique 4 and PainDETECT questionnaires

Camila Freitas de Andrade Rodrigues, Thiago Alves Rodrigues, Pedro Igor de Sousa Rios, Isabelle Nunes Costa, Bruno Feres de Souza, João Batista Santos Garcia

Hematol Transfus Cell Ther. 2026;48:106231

449

Full text access

Share

432

National multiple myeloma cohort: Gaps and opportunities for research in Brazil

Diogo Moreira do Amaral

Hematol Transfus Cell Ther. 2026;48:106229

432

Full text access

Share

422

Plasma levels of soluble podoplanin are higher in acute promyelocytic leukemia compared to other forms of acute myeloid leukemia

Carla Roberta Peachazepi Moraes, Camilla Maria de Alencar Saraiva, Ivanio Teixeira Borba-Junior, Bruno Kosa Lino Duarte, Paula Melo de Campos, Sara Teresinha Olalla Saad, Erich Vinicius De Paula

Hematol Transfus Cell Ther. 2026;48:106227

422

Full text access

Share

Publish in

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Idiomas

Hematology, Transfusion and Cell Therapy

Home
All contents
Publish your article
About the journal
- Aims and scope
- Editorial Board
Metrics